🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is a Phase II study. All patients are resectable Gastric or Gast...
Status
Recruiting
Location
Tianjin Provincial Tumor Hospital
Start Date
2023-11-13
Trial ID
NCT05960955
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
1998-05
Trial ID
NCT00003925
Treatments Being Tested
Recently, a number of clinical studies were carried out to evaluate the the...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10
Trial ID
NCT05594381
Treatments Being Tested
This study is for patients with esophageal cancer that has spread to other ...
Status
Unknown
Location
University of Maryland Cancer Center
Start Date
TBD
Trial ID
NCT00037089
Treatments Being Tested
This is a prospective, single arm, multicenter phase II study to assess the...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-15
Trial ID
NCT06439550
Treatments Being Tested
This study is designed to compare the three chemotherapy regimens(TEGAFOX S...
Status
Unknown
Location
Second Hospital Affiliated to Lanzhou University
Start Date
2013-05
Trial ID
NCT02817425
Treatments Being Tested
According to the investigator's judgment, there are concomitant diseases th...
Status
Unknown
Location
Shengjing Hospital of China Medical University
Start Date
2021-09-07
Trial ID
NCT05070598
Treatments Being Tested
Biliary tract cancer (BTC) presents with a 5-year survival rate less than 5...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Sun Yat-sen University
Start Date
2024-11-25
Trial ID
NCT06662877
Among resectable biliary tract cancers (BTC) patients, surgery has historic...
Status
Terminated
Location
Peing University Cancer Hospital
Start Date
2024-12-31
Trial ID
NCT06739252
Treatments Being Tested
Iressa \[epidermal growth factor tyrosine kinase inhibitor (EGFR-TKI)\] has...
Status
Completed
Location
Taipei VGH
Start Date
2005-11
Trial ID
NCT01037998
Treatments Being Tested